← Back to Search

Behavioral Intervention

Virtual Reality Meditation for Anxiety

N/A
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age between 18-99
between age 18-99
Must not have
History of seizures caused by flashing light
Significant cognitive impairment or inability to consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before and immediate after intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to determine if using virtual reality devices can help reduce anxiety and improve mood and satisfaction in adult patients who are currently in the hospital.

Who is the study for?
This trial is for English-speaking adults aged 18-99 who are currently hospitalized at Stanford Health Care. It's designed to help those experiencing anxiety.
What is being tested?
The study tests if using a Virtual Reality headset with calming scenery can reduce anxiety in hospitalized patients. Participants will be randomly assigned to use the VR device and their anxiety levels will be measured.
What are the potential side effects?
Since the intervention involves non-invasive virtual reality, side effects may include dizziness or nausea due to motion sickness, eye strain, or disorientation upon removal of the headset.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 99 years old.
Select...
I am between 18 and 99 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had seizures triggered by flashing lights.
Select...
I do not have significant cognitive issues and can consent.
Select...
I am currently experiencing nausea.
Select...
I do not need urgent medical care right now.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before and immediate after intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and before and immediate after intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hospital Anxiety and Depression Scale (HADS)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual RealityExperimental Treatment1 Intervention
Participants will be immersed in a virtual environment. Calming scenery will be shown via the headset for 20-30 minutes
Group II: ControlActive Control1 Intervention
No intervention (i.e. virtual reality headset) will be applied to the participant.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,467 Previous Clinical Trials
17,495,902 Total Patients Enrolled
33 Trials studying Anxiety
23,506 Patients Enrolled for Anxiety
Thomas CarusoStudy DirectorStanford University
2 Previous Clinical Trials
240 Total Patients Enrolled
~133 spots leftby May 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top